Practice
Featured experience
Purdue Pharma completes chapter 11 restructuring
We advised Purdue in connection with its nearly seven year-long chapter 11 restructuring
Anthology chapter 11 restructuring
We advised an ad hoc group of creditors on the restructuring
Azul emerges from chapter 11
We advised Azul in connection with its chapter 11 restructuring
QVC prepackaged chapter 11 filing and restructuring support agreement
We are advising an ad hoc group of noteholders in connection with QVC’s chapter 11 proceedings
Philadelphia Energy Restructuring and $120 Million DIP Financing Facility
Davis Polk is advising a group of prepetition term loan B lenders under a $550 million credit facility in the chapter 11…
The J.G. Wentworth Company’s Chapter 11 Plan of Reorganization
Davis Polk advised the administrative agent for the $449.5 million prepetition senior secured credit facility of The J.G…
Avaya $3.225 billion exit financing credit facilities
Davis Polk advised the joint lead arrangers, joint bookrunners and the joint co-managers with respect to a $2.925…
Davis Polk Advises Ad Hoc Group of Noteholders in Connection with Private Exchange with Denbury Resources Inc.
Davis Polk advised an ad hoc group of noteholders in connection with their private exchange with Denbury Resources Inc. of…
The J.G. Wentworth Company Reaches Restructuring Support Agreement with Lenders
Davis Polk is advising the administrative agent for The J.G. Wentworth Company’s $449.5 million senior secured credit…
Avaya $2.725 billion exit financing credit facilities
Davis Polk is advising the joint lead arrangers, joint bookrunners and joint co-managers with respect to a $2.425…
Toys “R” Us $2.3 billion DIP financing
Davis Polk is advising the administrative agent, collateral agent, joint lead arranger and bookrunner in connection with a …
TerraVia Enters Into an Agreement for Sale of Substantially All of Its Assets Subject to Competitive Bidding Process and Files for Chapter 11
Davis Polk is advising TerraVia Holdings, Inc. in connection with its restructuring under chapter 11 of the U.S. Bankruptcy…
Davis Polk Advises Pernix Therapeutics Holdings, Inc. on Its Refinancing Transactions
Davis Polk advised Pernix Therapeutics Holdings, Inc. in connection with a series of refinancing transactions that are…
Synchronoss Technologies, Inc. $1.1 billion Credit Facility Amendment
Davis Polk advised an ad hoc group of lenders holding approximately $700 million of term loans in connection with an…